SERBER ZACHARIAH (Chief Science Officer) sold 0.4% of their position (9.45K shares) of ZYMERGEN INC. on the open market
Open‑market sale worth $37.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/1/2022ACC: 0001645842-22-000023
DirectorOfficer· Chief Science Officer
Since Apr 2021
-9.45K
Net shares
Net seller
$37.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
9.45K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−4.01K
Price / share
$3.91
Trade value
$15.69K
% of position
0.2%
2/25/2022
2.37M→2.37M
Common Stock
Direct
Shares
−5.43K
Price / share
$3.93
Trade value
$21.35K
% of position
0.2%
2/28/2022
2.37M→2.36M
Total
Net shares
−9.45K
Net value
-$37.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/25/2022 | S · Sale | −4.01K | $3.91 | $15.69K | 0.2% | 2.37M | 2.37M |
| Common Stock Direct | 2/28/2022 | S · Sale | −5.43K | $3.93 | $21.35K | 0.2% | 2.37M | 2.36M |
| Total | −9.45K | -$37.04K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned40K
Common Stock
IndirectShares owned40K
Total
80K indirect80K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 40K | Indirect |
| Common Stock | 40K | Indirect |
| Total | 80K | 80K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported